23 Dec 2008 12:13
| TR-1: Notifications of Major Interests in Shares |
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Immunodiagnostic Systems Holdings PLC | ||
| 2. Reason for notification (yes/no) | |||
| An acquisition or disposal of voting rights | |||
| An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||
| An event changing the breakdown of voting rights | |||
| Other (please specify): Dillution due to issuance of additional 2,397, 268 shares | X | ||
| 3. Full name of person(s) subject to notification obligation: | Nordic Bioscience A/S | ||
| 4. Full name of shareholder(s) (if different from 3): | |||
| 5. Date of transaction (and date on which the threshold is crossed or reached if different): | December 10, 2008 | ||
| 6. Date on which issuer notified: | December 10,2008 | ||
| 7. Threshold(s) that is/are crossed or reached: | Our shareholding fell from 11,59% to 10,54% | ||
| 8. Notified details: | |||
| A: Voting rights attached to shares | ||||||||
| Class/type of shares If possible use ISIN code | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||
| Number of shares | Number of voting rights | Number of shares | Number of voting rights | Percentage of voting rights | ||||
| Direct | Indirect | Direct | Indirect | |||||
| B: Financial Instruments | ||||
| Resulting situation after the triggering transaction | ||||
| Type of financial instrument | Expiration date | Exercise/ conversion period/date | No. of voting rights that may be acquired (if the instrument exercised/converted) | Percentage of voting rights |
| Total (A+B) | |
| Number of voting rights | Percentage of voting rights |
|
|
|
| 9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable: |
| Proxy Voting: | |
| 10. Name of proxy holder: | |
| 11. Number of voting rights proxy holder will cease to hold: | |
| 12. Date on which proxy holder will cease to hold voting rights: | |
| 13. Additional information: | |
| 14 Contact name: | Thomas Nielsen, CFO |
| 15. Contact telephone name: | +45 4454 7705 |